Terpenoid ID | TKC152742 | |
Chirality | TKC057392 | |
Cell line | 0 | |
Protein target | 4 | |
DiseaseNCIT | 0 | |
ORDO | 0 | |
ICD | 15 |
ID | Cell Line | Synonyms | Value | Unit | Type | NCIt | ORDO |
---|---|---|---|---|---|---|---|
TKC152742 | H9 | HT clone H9; HT(H9); H 9; H-9 | 23000.0 | nM | EC50 | C3366 | Orphanet_3162 |
TKC152742 | J774 | J-774 | 67100.0 | nM | IC50 | C134780 | |
TKC152742 | Raji | RAJI; P1-Raji; GM04671 | 80.0 | % | Activity | C27694 | Orphanet_543 |
TKC152742 | HL-60 | HL 60; HL.60 HL60; Human Leukemia-60 | 30940.0 | nM | IC50 | C9154 | Orphanet_519 |
TKC152742 | MCF7 | 43880.0 | nM | IC50 | C4194 | ||
TKC152742 | DLD-1 | DLD 1; DLD1; CoCL3 | 6600.0 | nM | IC50 | C4349 | |
TKC152742 | A549 | 3800.0 | nM | IC50 | C3512 | ||
TKC152742 | B16 | B-16; B16 melanoma; B16 subline B78; B78 | 27400.0 | nM | IC50 | C21790 | |
TKC152742 | WI-38 VA13 | WI 38 VA13 subline 2RA; WI 38 VA-13 subline 2RA; WI 38VA13 subline 2RA; WI-38 VA13 sub 2 RA; WI38-VA13 subline 2RA; WI38 VA13/2RA; WI38VA13/2RA; VA13 2RA; WI-38 VA13; WI 38 VA 13; WI38-VA13; WI38/VA13; WI38VA13; VA-13; VA13; AG07217; AG7217 | 20300.0 | nM | IC50 | ||
TKC152742 | A2780 | A-2780; 2780; A2780S; A2780par | 6100.0 | nM | IC50 | C7979 | Orphanet_454723 |
TKC152742 | ADR5000 cell line | CCRF ADR5000; CCRF-ADR5000; CEM/ADR5000; CEM/ADR 5000; CEM-ADR5000; CEM ADR5000; ADR5000 | 56500.0 | nM | IC50 | C7953 | Orphanet_99861 |
TKC152742 | SN12C | SN-12C | 24831.0 | nM | GI50 | C9385 | Orphanet_217071 |
TKC152742 | MDA-N | MDAN | 44978.0 | nM | GI50 | C3802 | |
TKC152742 | NCI-H23 | NCI.H23; NCI H23; H-23; H23; NCIH23 | 94842.0 | nM | GI50 | C3512 | |
TKC152742 | ACHN | 11143.0 | nM | GI50 | C6975 | Orphanet_319298 | |
TKC152742 | UO-31 | UO.31; UO31; U031 | 11092.0 | nM | GI50 | C9385 | Orphanet_217071 |
TKC152742 | HOP-92 | HOP 92; HOP.92; HOP92; Hop92; Hopkins-92 | 16711.0 | nM | GI50 | C2926 | |
TKC152742 | SF-539 | SF-539; SF-539 BT; SF.539; SF 539 | 11749.0 | nM | GI50 | C3796 | Orphanet_251576 |
TKC152742 | DU-145 | DU-145; Du-145; DU 145; DU_145; DU.145; Duke University 145 | 136700.0 | nM | IC50 | C4863 | |
TKC152742 | Malme-3M | MALME-3M; MALME 3M; Malme-3 M; MALME.3M; Malme3M; MALME3M; Malme-3 Monolayer | 52481.0 | nM | GI50 | C3224 | |
TKC152742 | SK-MEL-5 | SK-Mel-5; SK MEL 5; SK.MEL.5; SK-MEL5; SKMel-5; SKMEL-5; SKMEL5; SKMel5; SKmel5; AA-Mel | 19679.0 | nM | GI50 | C3510 | |
TKC152742 | A498 | A498 | 21528.0 | nM | GI50 | C9385 | Orphanet_217071 |
TKC152742 | OVCAR-3 | Ovcar-3; OVCAR 3; OVCAR.3; NIH:OVCAR-3; NIH:Ovcar-3; NIH:OVCAR3; NIH-OVCAR-3; NIHOVCAR3; OVCAR3; Ovcar3 | 10000.0 | nM | IC50 | C105555 | |
TKC152742 | HOP-62 | HOP 62; Hop 62; HOP.62; HOP62; Hop62; Hopkins-62 | 16672.0 | nM | GI50 | C3512 | |
TKC152742 | MOLT-4 | Molt-4; MOLT 4; Molt 4; MOLT.4; MOLT4; Molt4; GM02219; GM02219C; GM2219C; GM02219D | 32359.0 | nM | GI50 | C9142 | Orphanet_99861 |
TKC152742 | NCI/ADR-RES | NCI/ADR-RES; NCI.ADR.RES; NCIADR.RES; NCI/ADRRES; NCIADRRES; ADR-RES; MCF-7/ADR; MCF-7/ADR-RES; MCF-7/AdrR; MCF-7/Adr; MCF-7/adr; MCF-7ADR; MCF7-ADR; MCF7ADR; OVCAR-8/ADR; OVCAR8/ADR | 30409.0 | nM | GI50 | C105555 | |
TKC152742 | U-251 | U-251 MG; U-251-MG; U-251_MG; U251-MG; U251MG; U-251; U251; U251n; U251N; 251 MG; 251MG; 251 MG(6) | 11803.0 | nM | GI50 | C60781 | Orphanet_94 |
TKC152742 | OVCAR-8 | OVCAR 8; NIH:OVCAR-8; OVCAR8; Ovcar8; OVCAR.8; OVCA8 | 12531.0 | nM | GI50 | C105555 | |
TKC152742 | OVCAR-5 | OVCAR 5; NIH:OVCAR-5; OVCAR.5; OVCAR5; Ovcar5; OVCA5 | 55719.0 | nM | GI50 | C105555 | |
TKC152742 | MDA-MB-231 | MDA_MB_231; MDA-MB 231; MDA.MB.231; MDA MB 231; MDA MB231; MDA Mb231; MDA-MB231; MDAMB-231; MDAMB231; MDA-231; MDA-231P; MDA231; MDA231-BRE; MB231; MD Anderson-Metastatic Breast-231 | 96190.0 | nM | IC50 | C5214 | |
TKC152742 | TK-10 | TK.10; TK 10; TK10 | 17100.0 | nM | GI50 | C4033 | Orphanet_319276 |
TKC152742 | SR | SR-786; SR786 | 42954.0 | nM | GI50 | C37193 | Orphanet_300895 |
TKC152742 | SW-620 | SW-620; SW 620; SW.620 | 20137.0 | nM | GI50 | C4349 | |
TKC152742 | KM12 | KM-12; KM.12 | 9705.0 | nM | GI50 | C4910 | |
TKC152742 | NCI-H522 | NCI.H522; H522; H-522; NCI-522; NCI522; NCIH522 | 20370.0 | nM | GI50 | C3512 | |
TKC152742 | M14 | M14-MEL; UCLA-SO-M14; UCLA SO M14; UCLA-SO-14; UCLASO-M14; Melanoma 14; M-14 | 51051.0 | nM | GI50 | C3802 | |
TKC152742 | NCI-H322M | NCI.H322M; H322M; H-322M; H-322m | 3581.0 | nM | GI50 | C2923 | |
TKC152742 | LOX IMVI | LOX/IMVI; LOX IMVI; LOXIM-VI; LOXIMVI; LOX | 14622.0 | nM | GI50 | C3802 | |
TKC152742 | BT-549 | BT 549; BT.549; BT549 | 17579.0 | nM | GI50 | C4194 | |
TKC152742 | SNB-75 | SNB.75; SNB75; Surgical Neurology Branch-75 | 12735.0 | nM | GI50 | C3058 | Orphanet_360 |
TKC152742 | HCT-15 | HCT-15; HCT.15; HCT15 | 42560.0 | nM | GI50 | C4349 | |
TKC152742 | HCT-116 | HCT-116; HCT.116; HCT_116; HCT116; HCT116wt; CoCL2 | 30832.0 | nM | GI50 | C4910 | |
TKC152742 | SF-268 | SF-268; SF.268; SF 268 | 25119.0 | nM | GI50 | C60781 | Orphanet_94 |
TKC152742 | EKVX | 25586.0 | nM | GI50 | C3512 | ||
TKC152742 | T47D | 20720.0 | nM | IC50 | C4194 | ||
TKC152742 | NCI-H460 | NCI.H460; H460; H-460; NCIH460; NCI-HUT-460; NCI-460 | 7.0 | ug.mL-1 | GI50 | C4450 | |
TKC152742 | CAKI-1 | CAL 1; Centre Antoine Lacassagne-1 | 15346.0 | nM | GI50 | C3224 | |
TKC152742 | MDA-MB-435 | MDA-MB435; MDAMB435; MDA.MB.435; MDA-435; MDA 435; MDA435; MD Anderson-Metastatic Breast-435 | 10000.0 | nM | IC50 | C3802 | |
TKC152742 | SF-295 | SF-295; SF.295; SF 295 | 14028.0 | nM | GI50 | C3058 | Orphanet_360 |
TKC152742 | IGROV-1 | Igrov-1; IGROV 1; IGR-OV1; IGROV1; Igrov1; IGR.OV1; IGROV; OV1/P; OV1/p; OV1-P | 34754.0 | nM | GI50 | C7979 | Orphanet_454723 |
TKC152742 | UACC-257 | UACC 257; UACC.257; UACC257; University of Arizona Cell Culture-257 | 23281.0 | nM | GI50 | C3224 | |
TKC152742 | 786-0 | 786-o; 786O; 786-0; 786.O; 786-O RCC; RCC 786-O; RCC_7860; RCC 7860; 7860; 786-0WT | 13614.0 | nM | GI50 | C9385 | Orphanet_217071 |
TKC152742 | NCI-H226 | NCI.H226; NCI H226; H226; H-226; HUT-226; HUT 226; NCIH226 | 38994.0 | nM | GI50 | C45662 | Orphanet_50251 |
TKC152742 | SK-MEL-28 | SK-Mel-28; SK.MEL.28; SK-MEL 28; SK MEL-28; SK MEL 28; SK Mel 28; SKMel-28; SKMEL-28; SK-MEL28; SK-Mel28; SK Mel28; SKMEL28; SKMel28; SKmel28; SKML-28; SK28; AU-Mel; P-36; P36 | 33113.0 | nM | GI50 | C3510 | |
TKC152742 | RXF 393 | RXF393L; RXF-393 L; RXF-393; RXF 393; RXF.393; RXF393; RXF 393NL | 10257.0 | nM | GI50 | C9385 | Orphanet_217071 |
TKC152742 | MGC-803 | MGC803; MGc80-3 | 30200.0 | nM | IC50 | C5248 | |
TKC152742 | Bcap37 | BCap-37; Bcap-37; BCaP 37; BCap 37; Bcap 37; BCAP37; Bcap37 | 25500.0 | nM | IC50 | C27677 | |
TKC152742 | A-375 | A 375; A375; A375-MEL; A375-mel; A375mel | 28000.0 | nM | IC50 | C3802 | |
TKC152742 | HepG2 | 10700.0 | nM | IC50 | C3728 | Orphanet_449 | |
TKC152742 | BXPC-3 | BxPc-3; BXPC-3; Bx-PC3; BXPC3; BxPC3; BxPc3; Biopsy xenograft of Pancreatic Carcinoma line-3 | 9.0 | ug.mL-1 | GI50 | C9120 | |
TKC152742 | PANC-1 | Panc-1; PANC.1; Panc 1; PanC1; Panc1; PANC1; Panc-1-P | 8.0 | uM | PC50 | C9120 |
ID | Uniport | Pref_name | Gene name | value | unit | type |
---|---|---|---|---|---|---|
TKC152742 | Q9NPD5 | Solute carrier organic anion transporter family member 1B3 | SLCO1B3 | 92 | % | Inhibition |
TKC152742 | Q9Y6L6 | Solute carrier organic anion transporter family member 1B1 | SLCO1B1 | 106 | % | Inhibition |
TKC152742 | Q04206 | Transcription factor p65 | RELA | 8800 | nM | IC50 |
TKC152742 | Q04206 | Transcription factor p65 | RELA | 8800 | nM | IC50 |
TKC152742 | O42275 | Acetylcholinesterase | ache | 7 | % | Inhibition |
TKC152742 | P0DTD1 | Replicase polyprotein 1ab | rep | 10 | % | Inhibition |
TKC152742 | P35354 | Prostaglandin G/H synthase 2 | PTGS2 | <30 | % | Inhibition |
TKC152742 | P81908 | Cholinesterase | BCHE | 0 | % | Inhibition |
TKC152742 | Q9WKE8 | Reverse transcriptase | reverse transcriptase | >200 | ug.mL-1 | IC50 |
TKC152742 | P05771 | Protein kinase C beta type | PRKCB | >150000 | nM | IC50 |
TKC152742 | Q02156 | Protein kinase C epsilon type | PRKCE | >150000 | nM | IC50 |
TKC152742 | Q96RI1 | Bile acid receptor | NR1H4 | 0 | nM | EC50 |
TKC152742 | P11388 | DNA topoisomerase 2-alpha | TOP2A | 38600 | nM | IC50 |
TKC152742 | P00690 | Pancreatic alpha-amylase | AMY2 | >200000 | nM | IC50 |
TKC152742 | P00489 | Glycogen phosphorylase, muscle form | PYGM | 16982 | nM | IC50 |
TKC152742 | P00489 | Glycogen phosphorylase, muscle form | PYGM | 17000 | nM | IC50 |
TKC152742 | P00489 | Glycogen phosphorylase, muscle form | PYGM | 41500 | nM | IC50 |
TKC152742 | Q8TDU6 | G-protein coupled bile acid receptor 1 | GPBAR1 | >0 | % | Efficacy |
Uniport ID | Uniport Name | ICD-11 |
---|---|---|
P35354 | PGH2_HUMAN | Alzheimer disease [ICD-11: 8A20] |
P35354 | PGH2_HUMAN | Chronic pain [ICD-11: MG30] |
P35354 | PGH2_HUMAN | Endometriosis [ICD-11: GA10] |
P35354 | PGH2_HUMAN | Female pelvic pain [ICD-11: GA34] |
P35354 | PGH2_HUMAN | Hyper-lipoproteinaemia [ICD-11: 5C80] |
P35354 | PGH2_HUMAN | Indeterminate colitis [ICD-11: DD72] |
P35354 | PGH2_HUMAN | Knee osteoarthritis [ICD-11: FA01] |
P35354 | PGH2_HUMAN | Migraine [ICD-11: 8A80] |
P35354 | PGH2_HUMAN | Osteoarthritis [ICD-11: FA00-FA05] |
P35354 | PGH2_HUMAN | Pain [ICD-11: MG30-MG3Z] |
P35354 | PGH2_HUMAN | Rheumatoid arthritis [ICD-11: FA20] |
P35354 | PGH2_HUMAN | Tuberculosis [ICD-11: 1B10-1B12] |
P35354 | PGH2_HUMAN | Shoulder lesion [ICD-11: FB53] |
P35354 | PGH2_HUMAN | Soft tissue disorder [ICD-11: FB56] |
P35354 | PGH2_HUMAN | Solid tumour/cancer [ICD-11: 2A00-2F9Z] |
P35354 | PGH2_HUMAN | Asthma [ICD-11: CA23] |
P35354 | PGH2_HUMAN | Gout [ICD-11: FA25] |
P35354 | PGH2_HUMAN | General pain disorder [ICD-11: 8E43] |
P35354 | PGH2_HUMAN | Lupus erythematosus [ICD-11: 4A40] |
P35354 | PGH2_HUMAN | Postoperative inflammation [ICD-11: 1A00-CA43] |
P35354 | PGH2_HUMAN | Large intestine polyp [ICD-11: DB35] |
P35354 | PGH2_HUMAN | Lung cancer [ICD-11: 2C25] |
P35354 | PGH2_HUMAN | Pancreatic cancer [ICD-11: 2C10] |
P35354 | PGH2_HUMAN | Type 2 diabetes mellitus [ICD-11: 5A11] |
P35354 | PGH2_HUMAN | Colorectal cancer [ICD-11: 2B91] |
P35354 | PGH2_HUMAN | Fever [ICD-11: MG26] |
P35354 | PGH2_HUMAN | Malignant haematopoietic neoplasm [ICD-11: 2B33] |
P05771 | KPCB_HUMAN | Brain cancer [ICD-11: 2A00] |
P05771 | KPCB_HUMAN | Central nervous system disease [ICD-11: 8A04-8D87] |
P05771 | KPCB_HUMAN | Diffuse large B-cell lymphoma [ICD-11: 2A81] |
P05771 | KPCB_HUMAN | Lymphoma [ICD-11: 2A80-2A86] |
P05771 | KPCB_HUMAN | Malignant haematopoietic neoplasm [ICD-11: 2B33] |
P05771 | KPCB_HUMAN | Solid tumour/cancer [ICD-11: 2A00-2F9Z] |
P05771 | KPCB_HUMAN | Transplant rejection [ICD-11: NE84] |
P05771 | KPCB_HUMAN | Mature B-cell leukaemia [ICD-11: 2A82] |
P05771 | KPCB_HUMAN | Rheumatoid arthritis [ICD-11: FA20] |
P05771 | KPCB_HUMAN | Human immunodeficiency virus disease [ICD-11: 1C60-1C62] |
Q02156 | KPCE_HUMAN | Anxiety disorder [ICD-11: 6B00-6B0Z] |
Q02156 | KPCE_HUMAN | Liver vascular disorder [ICD-11: DB98] |
Q02156 | KPCE_HUMAN | Malaria [ICD-11: 1F40-1F45] |
Q02156 | KPCE_HUMAN | Alzheimer disease [ICD-11: 8A20] |
Q02156 | KPCE_HUMAN | Postoperative inflammation [ICD-11: 1A00-CA43] |
Q02156 | KPCE_HUMAN | Human immunodeficiency virus disease [ICD-11: 1C60-1C62] |
Q96RI1 | NR1H4_HUMAN | Autoimmune liver disease [ICD-11: DB96] |
Q96RI1 | NR1H4_HUMAN | Cholelithiasis [ICD-11: DC11] |
Q96RI1 | NR1H4_HUMAN | Insomnia [ICD-11: 7A00-7A0Z] |
Q96RI1 | NR1H4_HUMAN | Osteoarthritis [ICD-11: FA00-FA05] |
Q96RI1 | NR1H4_HUMAN | Breast cancer [ICD-11: 2C60-2C6Y] |
Q96RI1 | NR1H4_HUMAN | Non-alcoholic fatty liver disease [ICD-11: DB92] |
Q96RI1 | NR1H4_HUMAN | Chronic kidney disease [ICD-11: GB61] |
Q96RI1 | NR1H4_HUMAN | Skeletal anomaly [ICD-11: LD24] |
Q96RI1 | NR1H4_HUMAN | Hepatic fibrosis/cirrhosis [ICD-11: DB93] |
Q96RI1 | NR1H4_HUMAN | Hyper-lipoproteinaemia [ICD-11: 5C80] |
Q96RI1 | NR1H4_HUMAN | Type 2 diabetes mellitus [ICD-11: 5A11] |
P11388 | TOP2A_HUMAN | Kaposi sarcoma [ICD-11: 2B57] |
P11388 | TOP2A_HUMAN | Solid tumour/cancer [ICD-11: 2A00-2F9Z] |
P11388 | TOP2A_HUMAN | Acute myeloid leukaemia [ICD-11: 2A60] |
P11388 | TOP2A_HUMAN | Mature T-cell lymphoma [ICD-11: 2A90] |
Q8TDU6 | GPBAR_HUMAN | Type 2 diabetes mellitus [ICD-11: 5A11] |
Q8TDU6 | GPBAR_HUMAN | Hepatic fibrosis/cirrhosis [ICD-11: DB93] |
Q8TDU6 | GPBAR_HUMAN | Metabolic disorder [ICD-11: 5C50-5D2Z] |